Overview

Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects

Status:
Not yet recruiting
Trial end date:
2022-12-20
Target enrollment:
Participant gender:
Summary
This clinical trial is a randomized, double-blind, single-center, placebo-controlled and multiple-dose escalation Pharmacokinetics study
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu vcare pharmaceutical technology co., LTD